Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors With Three Different Drug Combinations

PLoS ONE - United States
doi 10.1371/journal.pone.0161799
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

PARP-1 Regulates Resistance of Pancreatic Cancer to TRAIL Therapy

Clinical Cancer Research
Cancer ResearchOncology
2013English

PARP Inhibitors in Ovarian Cancer: Sensitivity Prediction and Resistance Mechanisms

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Treating Cancer With Phosphatidylinositol-3-Kinase Inhibitors: Increasing Efficacy and Overcoming Resistance

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2019English

PARP Inhibitors in Ovarian Cancer

2013English

Personalized Drug Combinations to Overcome Trastuzumab Resistance in HER2-positive Breast Cancer

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2014English

Barrier to Resistance of Dolutegravir in Two-Drug Combinations

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

The Inhibition and Treatment of Breast Cancer With Poly (ADP-ribose) Polymerase (PARP-1) Inhibitors

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2006English

Layer‐by‐Layer Nanoparticles for Novel Delivery of Cisplatin and PARP Inhibitors for Platinum‐Based Drug Resistance Therapy in Ovarian Cancer

Bioengineering & Translational Medicine
2019English

Overcoming Resistance to HER2 Inhibitors Through State-Specific Kinase Binding

Nature Chemical Biology
Cell BiologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy